Viva Biotech Holdings
Company Profile
Business description
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.
Contact
735 Ziping Road
Pudong New District
Zhoupu Town
Shanghai201318
CHNT: +86 2160893288
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
2,169
Stocks News & Analysis
stocks
What did Morningstar subscribers buy and sell during August?
stocks
Tesla: Shares fall as market disappointed with Cybercab launch event
stocks
The best global tech stocks to buy
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,981.30 | 50.20 | -0.56% |
| CAC 40 | 8,156.67 | 161.31 | -1.94% |
| DAX 40 | 25,576.45 | 431.18 | -1.66% |
| Dow JONES (US) | 52,380.66 | 405.41 | -0.77% |
| FTSE 100 | 10,670.06 | 141.60 | -1.31% |
| HKSE | 24,949.52 | 325.44 | -1.29% |
| NASDAQ | 26,253.34 | 168.07 | -0.64% |
| Nikkei 225 | 64,903.39 | 239.39 | -0.37% |
| NZX 50 Index | 13,701.69 | 117.74 | -0.85% |
| S&P 500 | 7,636.36 | 37.16 | -0.48% |
| S&P/ASX 200 | 8,789.80 | 48.20 | -0.55% |
| SSE Composite Index | 3,937.78 | 13.73 | -0.35% |